In the first part of this series, we discussed the Cell Danger Response (CDR), a defensive mechanism activated by cells in response to environmental stressors. The CDR is controlled by the mitochondria, which shift their metabolic state to focus on defending the cell instead of producing energy. This makes the cell more resistant to injuries. Once the CDR is activated, the cell enters a partially dormant state and signals nearby cells to do the same. Ideally, the CDR should proceed through three phases and then end, but this doesn’t always happen, leaving cells in a chronically impaired state. In the modern age, people are exposed to excessive stressors that surpass what the CDR was originally designed to handle, resulting in chronic activation of the CDR and the development of complex illnesses.
The concept of mitochondrial dysfunction as the root cause of many illnesses is gaining traction in the medical field, particularly in integrative medicine. Understanding the CDR provides important context to this paradigm, as it highlights that mitochondrial dysfunction is not a random occurrence that can be treated with supplements. Instead, it should be seen as an adaptive response, and treating mitochondrial dysfunction requires addressing the CDR itself.
I became interested in the CDR after discovering that the most effective treatments for spike protein injuries involved repairing the zeta potential of the body or addressing the danger response. I believe these are the primary issues in patients with spike protein injuries from vaccines. However, the available tools for treating the CDR are still limited and require a comprehensive understanding of the mechanism.
Traditional surgeries are often the only option to address certain bodily issues, but they can fail to fully resolve the problem or come with significant complications. As a result, I am always seeking alternative ways to mitigate the side effects of surgeries, finding skilled surgeons to refer patients to, and questioning the necessity and benefits of surgeries. Some complications from surgeries are easy to recognize, while others are more subtle. For example, the appendix plays a role in keeping cells out of the CDR, and its removal through appendectomy has been linked to autoimmune disorders and a decline in overall body functionality.
Regenerative medicine offers alternatives to surgery and focuses on reviving dormant cells. Various therapies fall under the umbrella of regenerative medicine, including neural therapy, prolotherapy, prolozone, placental extracts, extracellular matrix materials, platelet-rich plasma (PRP), exosomes, stem cells, and energy therapies targeting weakened tissues. These therapies are administered through targeted injections, implants during surgery, topical patches, or intravenous injections.
Regenerative medicine is commonly used as an alternative to orthopedic surgeries, and orthopedic surgeons often employ these therapies. There are two ways to approach regenerative medicine: a protocol-based approach where targeted therapy is directly administered to an injury, and a holistic approach that seeks to understand cellular dysfunction and shift the body’s momentum towards wellness and health. While both approaches have their benefits, I tend to lean towards the holistic approach because of the potential for miraculous recoveries involving failing organs or significant improvements in functionality.
In the holistic approach, determining why tissue has not regenerated on its own is crucial. It could be due to cells turning off or a lack of viable tissue that needs external replacement. Regardless, successful regenerative therapy requires providing nutritional support for healing or regeneration, addressing barriers to healing, identifying the area of the body that would benefit most from therapy, using high-quality regenerative medicine products, and understanding how the therapy may need to evolve over time.
Gaining expertise in each of these areas requires clinical experience. I have been fortunate to work with someone knowledgeable in regenerative medicine, who has taught me that in most cases, cells turning off is the primary issue rather than a lack of viable tissue. In the next part of this series, we will explore how this issue relates to… [content continues].